Document ID: chunk:federal_register_of_legislation:F2025C00158:clause:6_6
Version: federal_register_of_legislation:F2025C00158
Segment Type: clause
Provision Reference: sch 6 cl 6
Character Range: 18612292–18612873

6                               Patient:                               Any of the following:
                                (a) with any genotype; and             (a) sofosbuvir with velpatasvir for 12 weeks;
                                (b) who is treatment experienced; and  (b) sofosbuvir with velpatasvir and voxilaprevir for 12 weeks;
                                (c) who is cirrhotic                   (c) glecaprevir with pibrentasvir for 12 weeks;
                                                                       (d) glecaprevir with pibrentasvir for 16 weeks